Consortium of Investigators of Modifiers of BRCA1/2

Author PubWeight™ 10.47^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).	Cancer Epidemiol Biomarkers Prev	2011	1.99
2	AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.	Cancer Epidemiol Biomarkers Prev	2007	1.75
3	Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.	J Natl Cancer Inst	2010	1.41
4	Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.	Nat Commun	2013	1.36
5	BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.	Br J Cancer	2013	1.19
6	Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.	Cancer Epidemiol Biomarkers Prev	2012	1.17
7	The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.	Br J Cancer	2009	0.90
8	Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.	Hum Mol Genet	2011	0.89
9	SNP Set Association Testing for Survival Outcomes in the Presence of Intrafamilial Correlation.	Genet Epidemiol	2015	0.75